Identification | Back Directory | [Name]
4,7-Dihydro-2,2-diMethyl-1,3-dioxepin | [CAS]
1003-83-4 | [Synonyms]
NSC 693424 Gadobutrol Impurity 29 4,7-Dihydro-2,2-diMethyl-1,3-dioxepin 2,2-Dimethyl-1,3-dioxacyclohept-5-ene 2,2-DiMethyl-4,7-dihydro-1,3-dioxepine 4,7-Dihydro-2,2-dimethyl-1,3-dioxepine 1,3-Dioxepin, 4,7-dihydro-2,2-dimethyl- 2,2-dimethyl-4,7-dihydro-2H-1,3-dioxepine 2,2-Dimethyl-4,7-dihydro-2H-[1,3]dioxepin 2,2-Dimethyl-1,3-dioxacyclohept-5-ene ISO 9001:2015 REACH | [Molecular Formula]
C7H12O2 | [MDL Number]
MFCD22054122 | [MOL File]
1003-83-4.mol | [Molecular Weight]
128.169 |
Hazard Information | Back Directory | [Uses]
4,7-Dihydro-2,2-dimethyl-1,3-dioxepin is an intermediate in the synthesis of Calcobutrol (C145700), a new macrocyclic polyhydroxylated gadolinium chelate derivative which can be used as a contrast agent for Magnetic Resonance Imaging (MRI). |
|
Company Name: |
TCI Europe
|
Tel: |
320-37350700 |
Website: |
https://www.tcichemicals.com/de/de/index.html |
|